Aller au contenu principal
Profil bibliographique

David Wilds

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées
49Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Signaling Pathways in DiseaseProtein Kinase Regulation and GTPase SignalingCancer, Hypoxia, and MetabolismUbiquitin and proteasome pathwaysProtein Tyrosine Phosphatases

Les publications récentes

2026 conference-abstract OpenAlex

Abstract 6782: Discovery of a new class of mutant-targeted catalytic RAS(ON) inhibitors with retained antitumor activity in setting of emergent resistance due to elevated RAS flux

Kyle J. Seamon, Jingwei Yin, Ouma Onguka, Oliver Lai et autres

Abstract RAS family proteins regulate cell growth by transitioning between GTP-bound (ON) and GDP-bound (OFF) conformations. Transition to the OFF state is facilitated by endogenous GTPase activating proteins (GAPs). Oncogenic mutations in RAS - among the most prevalent genetic events in human …

us (code pays fourni par la source)

0 citations Cancer Research
2022 conference-abstract OpenAlex

Abstract 3597: Direct targeting of KRASG12X mutant cancers with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor

Elena S. Koltun, Meghan A. Rice, William Clay Gustafson, David Wilds et autres

Abstract Mutant RAS is common in pancreatic carcinoma (PDAC), non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) and exists predominantly in the GTP-bound (RAS(ON)) state, leading to excessive downstream oncogenic signaling. KRASG12C(OFF) inhibitors have provided clinical proof of concept for targeting …

us (code pays fourni par la source)

32 citations Cancer Research
2018 conference-abstract OpenAlex

Abstract 4878: RMC-4550, an allosteric inhibitor of SHP2: Synthesis, structure, and anti-tumor activity

Elena S. Koltun, Naing Aay, Andreas Buckl, Ashutosh S. Jogalekar et autres

Abstract Genetic and pharmacologic evidence has shown that SHP2, a non-receptor protein tyrosine phosphatase (PTP) and scaffold protein encoded by the PTPN11 gene, is a convergent signal transduction node that integrates growth factor signals from multiple receptors to promote activation of RAS …

us (code pays fourni par la source)

17 citations Cancer Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.